Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Bio-marker for Rheumatoid Arthritis
11 sept. 2018 10h05 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the leader in specialty rheumatology testing, announced today availability of the first validated blood test...
Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test
20 août 2018 11h20 HE
|
Exagen Diagnostics, Inc.
Albuquerque and San Diego, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test, see full...